Skip to main navigation Skip to search Skip to main content

Structure-Activity Relationship of Synthetic Toll-like Receptor 4 Agonists

  • Axel G. Stöver
  • , Jean Da Silva Correia
  • , Jay T. Evans
  • , Christopher W. Cluff
  • , Mark W. Elliott
  • , Eric W. Jeffery
  • , David A. Johnson
  • , Michael J. Lacy
  • , Jory R. Baldridge
  • , Peter Probst
  • , Richard J. Ulevitch
  • , David H. Persing
  • , Robert M. Hershberg
  • GlaxoSmithKline
  • Scripps Research Institute
  • Infectious Disease Research Institute
  • Dendreon

Research output: Contribution to journalArticlepeer-review

153 Scopus citations

Abstract

Important questions remain regarding the impact of variations in the structure of the lipid A portion of lipopolysaccharide on activation of cells via the Toll-like receptor 4 complex. We have studied a series of synthetic lipid A mimetic compounds known as aminoalkyl glucosaminide phosphates in which the length of the secondary acyl chain has been systematically varied. Using transcriptional profiling of human monocytes and responses of Toll-like receptor 4 complex cell transfectants, we demonstrate a clear dependence of length on secondary acyl chain on Toll-like receptor 4 activation. Compounds with secondary acyl chains less than eight carbons in length have dramatically reduced activity, and substitutions of the left-sided secondary acyl chain had the most important effect on the Toll-like receptor 4 agonist activity of these molecules. The structure-function relationships of these compounds assessed via the induction of chemokines and cytokines following in vivo administration closely mirrored those seen with cell-based studies. This novel set of synthetic lipid A mimetics will be useful for Toll-like receptor 4-based investigations and may have clinical utility as stand-alone immunomodulators.

Original languageEnglish
Pages (from-to)4440-4449
Number of pages10
JournalJournal of Biological Chemistry
Volume279
Issue number6
DOIs
StatePublished - Feb 6 2004

Fingerprint

Dive into the research topics of 'Structure-Activity Relationship of Synthetic Toll-like Receptor 4 Agonists'. Together they form a unique fingerprint.

Cite this